Your Source for Venture Capital and Private Equity Financings

Monogram Health Receives $160M Series B

2021-06-08
NASHVILLE, TN, Monogram Health today announced that it has closed a $160 million Series B funding round.
Monogram Health, a benefit management and care delivery company transforming care for individuals with chronic kidney and end-stage renal disease, today announced that it has closed a $160 million Series B funding round led by TPG Capital, the private equity platform of global alternative asset firm TPG. The funding round also includes existing investors Frist Cressey Ventures and Norwest Venture Partners, as well as Humana Inc. and other notable national and regional strategic investors.

Monogram Health is a leading kidney disease benefit management and care delivery company. It provides an innovative renal care model and data-driven array of clinical managed services, including complex case and disease management, utilization management, and medication therapy management to transform the delivery of care received by patients living with chronic kidney and end-stage renal disease. Partnering with health plans, physician practices, dialysis providers, and clinically integrated health systems, Monogram Health provides patients with exceptional at-home individualized clinical managed services and nephrology care delivery. Through the use of next generation artificial intelligence, evidence-based criteria, and personalized care planning, Monogram Health's model seeks to delay the progression of the disease, promote a seamless transition to dialysis, palliative care and/or pre-emptive kidney transplant, and optimize health outcomes for patients with end-stage renal disease.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors